EU Court rules in favour of lifting market exclusivity for cystic fibrosis drug

Market exclusivity for ‘Tobi Podhaler’ had not been unfairly lifted, the CJEU ruled on Friday.

Content-Type:

News Based on facts, either observed and verified directly by the reporter, or reported and verified from knowledgeable sources.

EU Court rules in favour of lifting market exclusivity for cystic fibrosis drug. [EPA-EFE/JULIEN WARNAND]

Euractiv is part of the Trust Project

Thomas Mangin Euractiv 07-10-2024 10:19 2 min. read Content type: News

Euractiv is part of the Trust Project

Facebook X LinkedIn Mail

Donec et orci aliquet nisl suscipit molestie sed sit amet tortor. Duis vel urna ac mi sollicitudin lacinia mollis sit amet lorem. Sed finibus erat nec libero scelerisque fringilla. Morbi at orci sed urna vulputate vulputate. Nulla facilisi. Donec et orci aliquet nisl suscipit molestie sed sit amet tortor.

Want to keep reading?

Get a subscription on Euractiv Pro and elevate your political insight!

Discover Euractiv Pro
For corporations

EU Court rules in favour of lifting market exclusivity for cystic fibrosis drug

Topics

More from this section

Subscribe to our newsletters